-The Times of India The transfer of the chairman of the National Pharmceutical Pricing Authority, Bhupendra Singh, who had capped the price of stents and knee implants and exposed the huge margins being charged by corporate hospitals has evoked howls of protest from public health activists. RSS-affiliate Swadeshi Jagran Manch too has taken exception to the move, tweeting sarcastically about the “reward” given to a bureaucrat for doing a good job. The All...
More »SEARCH RESULT
Total Matching Records found : 76
Private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics: Study -Rema Nagarajan
-The Times of India NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three accounts for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of...
More »Cardiac stent price cap lowered further to Rs 28,000 -Rema Nagarajan
-The Times of India The National Pharmaceutical Pricing Authority on Monday revised the price of drug eluting stents (DES) downwards by about Rs 2,300 to just under Rs 28,000, while marginally raising the cap on bare metal stents from Rs 7,400 to Rs 7,660. These caps are excluding GST. With DES accounting for about 95% of all stents used in India, this means most stents will become cheaper. The authority, which had...
More »Syringe prices may fall by half or more in January 2018 -Rema Nagarajan
-The Times of India NEW DELHI: The All India Syringes and Needles Manufacturers Association has issued a circular to its members to print the maximum retail price (MRP) on the basis of a maximum of 75% margin from December 24, which is observed as Consumer Day, and to implement this latest by January 26 next year. It also wrote to all foreign manufacturers of syringes, urging them to join the effort to...
More »Dengue death: Fortis kept profit margin as high as 1,737 per cent, finds NPPA -Abantika Ghosh
-The Indian Express Aadya died of dengue at the hospital in September, and her family was charged almost Rs 16 lakh for a 15-day stay. New Delhi: Fortis Hospital, Gurgaon made a 1,737 per cent profit on drugs and other consumables that it billed the family of seven-year-old Aadya Singh, the drug pricing regulator has found in an analysis. Aadya died of dengue at the hospital in September, and her family was charged...
More »
